| Aug 20, 2025 |
Aug 22, 2025 |
Intellia Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+100,000
|
288.24%
|
✗
|
$1M |
| Jun 26, 2019 |
Jun 28, 2019 |
AbbVie Inc.
|
EVP, Finance & Administration |
Buy |
100.0
|
+30,400
|
21.77%
|
✗
|
$2M |
| Feb 28, 2019 |
Mar 4, 2019 |
AbbVie Inc.
|
EVP, Finance & Administration |
Sell |
17.5
|
-27,276
|
-16.34%
|
✗
|
$2.2M |
| Dec 12, 2018 |
Dec 14, 2018 |
AbbVie Inc.
|
EVP, Finance & Administration |
Sell |
3.8
|
-60,000
|
-36.28%
|
✓
|
$5.4M |
| Feb 28, 2018 |
Mar 2, 2018 |
AbbVie Inc.
|
CFO |
Sell |
12.5
|
-99,335
|
-15.69%
|
✓
|
$11.7M |
| May 18, 2017 |
May 19, 2017 |
AbbVie Inc.
|
CFO |
Sell |
15.0
|
-38,300
|
-17.23%
|
✓
|
$2.5M |
| Feb 28, 2017 |
Mar 2, 2017 |
AbbVie Inc.
|
CFO |
Sell |
17.5
|
-40,212
|
-17.93%
|
✗
|
$2.5M |
| Dec 2, 2016 |
Dec 2, 2016 |
AbbVie Inc.
|
CFO |
Sell |
35.0
|
-6,600
|
-3.68%
|
✓
|
$390.7K |